Barsky, AJ, Orav, EJ, Bates, DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry
2005; 62: 903–10.
Henningsen, P, Zipfel, S, Herzog, W. Management of functional somatic syndromes. Lancet
2007; 369: 946–55.
Kroenke, K, Sharpe, M, Sykes, R. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics
2007; 48: 277–85.
Creed, F, Fink, P, Guthrie, E, Henningsen, P, Rief, W, Sharpe, M, et al. Is there a better term than ‘medically unexplained symptoms'?
J Psychosom Res
2010; 68: 5–8.
Fink, P, Schröder, A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndrome and somatoform disorders. J Psychosom Res
2010; 68: 415–25.
Kroenke, K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res
2003; 12: 34–43.
Kroenke, K, Swindle, R. Cognitive–behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom
2000; 69: 205–15.
Abbass, A, Kisely, S, Kroenke, K. Short-term psychodynamic psychotherapy for somatic disorders: systematic review and meta-analysis of clinical trials. Psychother Psychosom
2009; 78: 265–74.
Kroenke, K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med
2007; 69: 881–8.
Hardy, G, Barkham, M, Shapiro, D, Guthrie, E, Margison, F (eds). Psychodynamic-Interpersonal Psychotherapy. Sage, 2011
Kroenke, K, Spitzer, RL, deGruy, FV, Hahn, SR, Linzer, M, Williams, JB, et al. Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry
1997; 54: 352–8.
Spitzer, RL, Kroenke, K, Williams, JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA
1999; 282: 1737–44.
Ware, JE, Sherbourne, CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care
1992; 30: 473–83.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Biometrics Research, New York State Psychiatric Institute, 2002.
Folstein, MF, Folstein, SE, McHugh, PR. ‘Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res
1975; 12: 189–98.
Seivewright, H, Green, J, Salkovskis, P, Barrett, B, Nur, U, Tyrer, P. Cognitive–behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry
2008; 193: 332–7.
Rudolf, G, Henningsen, P. Psychotherapeutic treatment of somatoform disorders [in German]. Z Psychosom Med Psychother
2003; 49: 3–19.
Guthrie, E. Adaptation of the psychodynamic-interpersonal model to work with medically unexplained symptoms. In Psychodynamic-Interpersonal Psychotherapy (eds Hardy, G, Barkham, M, Shapiro, D, Guthrie, E, Margison, F). Sage, 2011
Henningsen, P, Working Group PISO. Psychodynamic-interpersonal therapy for somatoform disorders (PISO) – a manualized short-term psychotherapy [in German]. In Practice of Psychodynamic Psychotherapy
(eds Beutel, M, Doering, S, Leichsenring, F, Reich, G). Hogrefe, 2011
Rief, W, Henningsen, P. Somatoform disorders [in German]. In Practice of Psychotherapy
(eds Senf, W, Broda, M). Thieme, 2005.
Shapiro, DA, Startup, M. Measuring therapist adherence in exploratory psychotherapy. Psychother Res
1992; 2: 193–203.
Henningsen, P, Hartkamp, N, Loew, T, Sack, M, Scheidt, C, Rudolf, G. Somatoform Disorders. Guidelines and Source Book
. Schattauer, 2002.
Riddle, DL, Lee, KT, Stratford, PW. Use of SF-36 and SF-12 health status measures: a quantitative comparison for groups versus individual patients. Med Care
2001; 39: 867–78.
Wiebe, S, Matijevic, S, Eliasziw, M, Derry, PA. Clinically important change in quality of life in epilepsy. J Neurol Neurosurg Psychiatry
2002; 73: 116–20.
Creed, F, Fernandes, L, Guthrie, E, Palmer, S, Ratcliffe, J, Read, N, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology
2003; 124: 303–17.
Kleinstaeuber, M, Witthoeft, M, Hiller, W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev
2011; 31: 146–60.
Pilowsky, I. Dimensions of hypochondriasis. Br J Psychiatry
1967; 113: 89–93.
Fink, P, Ewald, H, Jensen, J, S⊘rensen, L, Engberg, M, Holm, M, et al. Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization. J Psychosom Res
1999; 46: 261–73.
Altman, DG, Schulz, KF, Moher, D, Egger, M, Davidoff, F, Elbourne, D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med
2001; 134: 663–94.
Cohen, J. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Erlbaum, 1988.
Looper, KJ, Kirmayer, LJ. Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol
2002; 70: 810–27.
Fonagy, P. Psychotherapy research: do we know what works for whom?
Br J Psychiatry
2010; 197: 83–5.
Roland, M, Torgerson, DJ. What are pragmatic trials?
1998; 316: 285.
Dickinson, WP, Dickinson, LM, deGruy, FV, Main, DS, Candib, LM, Rost, K. A randomized clinical trial of a care. recommendation letter intervention for somatization in primary care. Ann Fam Med
2003; 1: 228–35.
Sumathipala, A, Siribaddana, S, Abeysingha, MRN, De Silva, P, Dewey, M, Prince, M, et al. Cognitive–behavioural therapy v. structured care for medically unexplained symptoms: randomised controlled trial. Br J Psychiatry
2008; 193: 51–9.
Sattel, H, Kittner, A, Henningsen, P. A brief psychodynamic-interpersonal psychotherapy for patients with multisomatoform disorder (PISO) – one size fits all?
Psychother Psych Med
2011; 61: 111.
Krause, MS, Lutz, W. What should be used for baselines against which to compare treatments’ effectiveness?
2009; 19: 358–67.
Morriss, R, Dowrick, C, Salmon, P, Peters, S, Dunn, G, Rogers, A, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry
2007; 191: 536–42.
Guthrie, E, Moorey, J, Margison, F, Barker, H, Palmer, S, McGrath, G, et al. Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services. Arch Gen Psychiatry
1999; 56: 519–26.